NCT00630175View on ClinicalTrials.gov

Evaluation of the Hypnotic Properties of Zolpidem-MR 12.5 mg and Zolpidem 10 mg Marketed Product Compared to Placebo in Patients With Primary Insomnia

PHASE3CompletedINTERVENTIONAL
Enrollment

113

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

February 29, 2004

Study Completion Date

February 29, 2004

Conditions
Sleep Initiation and Maintenance Disorders
Interventions
DRUG

zolpidem-MR (modified release)

DRUG

zolpidem (SL800750)

DRUG

placebo

Trial Locations (3)

08807

Sanofi-Aventis Administrative Office, Bridgewater

Unknown

Sanofi-Aventis Administrative Office, Macquarie Park

Sanofi-Aventis Administrative Office, Laval

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY